Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
AssigneesUniversity of Iowa Research Foundation, University of Kansas
InventorsZiying Yan, John F. Engelhardt, Jianming Qiu
Life of this patent
Estimating the term…
Abstract
A method of preparing a chimeric virus comprising bocavirus capsid protein (VP) and a recombinant adeno-associated (AAV) viral genome, and isolated mutant bocavirus genomes, are provided.
Claims41
(canceled)
A method of preparing a chimeric virus comprising a bocavirus VP1 capsid polypeptide and a recombinant adeno-associated (AAV) viral genome, comprising:
- a) isolating the chimeric virus from a host cell that:
- (1) expresses the bocavirus VP1 capsid polypeptide, and
- (2) does not express one or more of the bocavirus NS1, NS2, NS4 polypeptides, or any combination thereof.
A host cell comprising a chimeric virus, the chimeric virus comprising a bocavirus VP1 capsid polypeptide and a recombinant adeno-associated (AAV) viral genome,
- wherein the host cell (1) expresses the bocavirus VP1 capsid polypeptide;
- and (2) does not express one or more of the bocavirus NS1, NS2, NS4 polypeptides, or any combination thereof.
A population of chimeric viruses, the population comprising a bocavirus VP1 capsid polypeptide and a recombinant adeno-associated (AAV) viral genome,
- wherein the population was isolated from a host cell capable of expressing the bocavirus VP1 capsid polypeptide;
- and
- wherein the host cell does not express one or more of bocavirus NS1, NS2, NS4 polypeptides, or any combination thereof.
A preparation comprising a chimeric virus, the chimeric virus comprising a bocavirus VP1 capsid polypeptide and a recombinant adeno-associated (AAV) viral genome,
- wherein the chimeric virus was produced by a host cell capable of expressing the bocavirus VP1 capsid polypeptide;
- and
- wherein the host cell does not express one or more of bocavirus NS1, NS2, NS4 polypeptides, or any combination thereof.
A method of treatment comprising:
- administering to a subject a chimeric virus comprising a bocavirus VP1 capsid polypeptide and a recombinant adeno-associated (AAV) viral genome,
- wherein the chimeric virus was isolated from a host cell that expresses the bocavirus VP1 capsid polypeptide;
- and
- wherein the host cell does not express one or more of bocavirus NS1, NS2, NS4 polypeptides, or any combination thereof.
A method of preparing a chimeric virus comprising bocavirus capsid protein and a recombinant adeno-associated (AAV) viral genome which method is independent of bocavirus NP1, comprising:
- a) providing a bocavirus genome vector that when introduced to mammalian cells
- i) express bocavirus NS3 and NS4 but not NS1 and NS2,
- ii) expresses bocavirus capsid proteins VP1, VP2 and VP3, and
- iii) does not express a functional bocavirus NP1,
- wherein the coding region for the one or more of the VP1, VP2 or VP3 in the bocavirus genome vector is codon optimized;
- b) introducing the bocavirus genome vector and a rAAV vector having an AAV genome into mammalian cells that do not express bocavirus NP1 in trans,
- thereby producing bocavirus nonstructural proteins NS3 and NS4, bocavirus capsid proteins and a rAAV genome;
- and
- c) collecting chimeric rAAV/bocavirus virus.
Dependencies are inferred from the claim text.